Literature DB >> 18365950

Understanding the motivations for recreational marijuana use among adult Canadians.

Geraint B Osborne1, Curtis Fogel.   

Abstract

The Canadian Special Senate Committee on Illegal Drugs (2003) noted that little ethnographic research had been devoted to exploring why people use marijuana recreationally or the social contexts in which it is used. The purpose of this exploratory qualitative research is to better understand both of these neglected topics through interviews conducted with 41 adult Canadian users between 2005 and 2006. The participants' ages ranged from 21 to 61 and included 25 males and 16 females whose consumption patterns ranged from sporadic use to regular daily use. They were predominantly middle class, employed in a wide range of occupations, and used marijuana recreationally to enhance relaxation and concentration while engaged in leisure activities. Implications for drug laws and policies are discussed. The study's limitations are noted.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365950     DOI: 10.1080/10826080701884911

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  16 in total

Review 1.  A review of the effects of nicotine on social functioning.

Authors:  Lea M Martin; Michael A Sayette
Journal:  Exp Clin Psychopharmacol       Date:  2018-06-28       Impact factor: 3.157

2.  It depends on when you ask: motives for using marijuana assessed before versus after a marijuana use event.

Authors:  Lydia A Shrier; Emily Blood Scherer
Journal:  Addict Behav       Date:  2014-07-18       Impact factor: 3.913

3.  Patterns of drug use and abuse among aging adults with and without HIV: a latent class analysis of a US Veteran cohort.

Authors:  Traci C Green; Trace Kershaw; Haiqun Lin; Robert Heimer; Joseph L Goulet; Kevin L Kraemer; Adam J Gordon; Steve A Maisto; Nancy L Day; Kendall Bryant; David A Fiellin; Amy C Justice
Journal:  Drug Alcohol Depend       Date:  2010-04-15       Impact factor: 4.492

Review 4.  A Clinical Framework for Assessing Cannabis-Related Impairment Risk.

Authors:  Caroline A MacCallum; Lindsay A Lo; Carly A Pistawka; April Christiansen; Michael Boivin; Melissa Snider-Adler
Journal:  Front Psychiatry       Date:  2022-06-24       Impact factor: 5.435

5.  Medical, therapeutic, and recreational use of cannabis among young men who have sex with men living with HIV.

Authors:  Douglas Bruce; Alida M Bouris; Shannon Bowers; Olivia Blocker; Soo Young Lee; Mary F Glidden; John A Schneider; Daniel H Reirden
Journal:  Addict Res Theory       Date:  2019-06-26

6.  Whither RDS? An investigation of Respondent Driven Sampling as a method of recruiting mainstream marijuana users.

Authors:  Andrew D Hathaway; Elaine Hyshka; Patricia G Erickson; Mark Asbridge; Serge Brochu; Marie-Marthe Cousineau; Cameron Duff; David Marsh
Journal:  Harm Reduct J       Date:  2010-07-09

7.  The Role of Study and Work in Cannabis Use and Dependence Trajectories among Young Adult Frequent Cannabis Users.

Authors:  Nienke Liebregts; Peggy van der Pol; Margriet Van Laar; Ron de Graaf; Wim van den Brink; Dirk J Korf
Journal:  Front Psychiatry       Date:  2013-08-09       Impact factor: 4.157

8.  Profiles of lifetime substance use are differentiated by substance of choice, affective motivations for use, and childhood maltreatment.

Authors:  Naomi Sadeh; Rickie Miglin; Nadia Bounoua; Emil Beckford; Suzanne Estrada; Arielle Baskin-Sommers
Journal:  Addict Behav       Date:  2020-10-14       Impact factor: 3.913

Review 9.  The importance of psychology for shaping legal cannabis regulation.

Authors:  Jacob T Borodovsky; Michael J Sofis; Richard A Grucza; Alan J Budney
Journal:  Exp Clin Psychopharmacol       Date:  2020-05-21       Impact factor: 3.157

Review 10.  Cannabis based medicines and cannabis dependence: A critical review of issues and evidence.

Authors:  Anne K Schlag; Chandni Hindocha; Rayyan Zafar; David J Nutt; H Valerie Curran
Journal:  J Psychopharmacol       Date:  2021-02-17       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.